{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:08:05Z","timestamp":1793412485721,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"crossref","award":["F2-2008-223077"],"award-info":[{"award-number":["F2-2008-223077"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["PIEF-GA-2009-254127"],"award-info":[{"award-number":["PIEF-GA-2009-254127"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2011-23051"],"award-info":[{"award-number":["SAF2011-23051"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CSD2008-00005"],"award-info":[{"award-number":["CSD2008-00005"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI12\/00884"],"award-info":[{"award-number":["FIS PI12\/00884"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEO-2009-027"],"award-info":[{"award-number":["PROMETEO-2009-027"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["ACOMP\/2014\/026"],"award-info":[{"award-number":["ACOMP\/2014\/026"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12974-015-0404-7","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:19:38Z","timestamp":1443572378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients"],"prefix":"10.1186","volume":"12","author":[{"given":"Jofre","family":"Tenorio-Laranga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmina","family":"Montoliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Urios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Hernandez-Rabaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Ahabrach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9680-717X","authenticated-orcid":false,"given":"J. Arturo","family":"Garc\u00eda-Horsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Felipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,30]]},"reference":[{"issue":"4","key":"404_CR1","first-page":"222","volume":"7","author":"RT Frederick","year":"2011","unstructured":"Frederick RT. Current concepts in the pathophysiology and management of hepatic encephalopathy. Gastroenterol Hepatol (N Y). 2011;7(4):222\u201333.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"5","key":"404_CR2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1440-1746.2001.02487.x","volume":"16","author":"A Das","year":"2001","unstructured":"Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol. 2001;16(5):531\u20135.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"404_CR3","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1111\/j.1572-0241.2001.04130.x","volume":"96","author":"M Romero-G\u00f3mez","year":"2001","unstructured":"Romero-G\u00f3mez M, Boza F, Garc\u00eda-Valdecasas MS, Garc\u00eda E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96(9):2718\u201323.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"404_CR4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","volume":"35","author":"P Ferenci","year":"2002","unstructured":"Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716\u201321.","journal-title":"Hepatology"},{"issue":"2","key":"404_CR5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/hep.21734","volume":"46","author":"O Cauli","year":"2007","unstructured":"Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology. 2007;46(2):514\u20139.","journal-title":"Hepatology"},{"issue":"2","key":"404_CR6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1053\/j.gastro.2010.03.040","volume":"139","author":"R Rodrigo","year":"2010","unstructured":"Rodrigo R, Cauli O, Gomez-Pinedo U, Agusti A, Hernandez-Rabaza V, Garcia-Verdugo JM, et al. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology. 2010;139(2):675\u201384.","journal-title":"Gastroenterology"},{"issue":"2","key":"404_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2003.10.016","volume":"40","author":"DL Shawcross","year":"2004","unstructured":"Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004;40(2):247\u201354.","journal-title":"J Hepatol"},{"issue":"3","key":"404_CR8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31815e7f58","volume":"43","author":"C Montoliu","year":"2009","unstructured":"Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, Rodrigo JM, et al. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J of Clin Gastroenterol. 2009;43(3):272\u20139.","journal-title":"J of Clin Gastroenterol"},{"issue":"11","key":"404_CR9","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/gut.2010.236083","volume":"60","author":"A Agusti","year":"2011","unstructured":"Agusti A, Cauli O, Rodrigo R, Llansola M, Hern\u00e1ndez-Rabaza V, Felipo V. p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts. Gut. 2011;60(11):1572\u20139.","journal-title":"Gut"},{"issue":"5","key":"404_CR10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1358\/dnp.2007.20.5.1120216","volume":"20","author":"PT M\u00e4nnist\u00f6","year":"2007","unstructured":"M\u00e4nnist\u00f6 PT, Ven\u00e4l\u00e4inen J, Jalkanen A, Garc\u00eda-Horsman JA. Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders. Drug News Perspect. 2007;20(5):293\u2013305.","journal-title":"Drug News Perspect"},{"issue":"1","key":"404_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2006.10.004","volume":"41","author":"JA Garc\u00eda-Horsman","year":"2007","unstructured":"Garc\u00eda-Horsman JA, M\u00e4nnist\u00f6 PT, Ven\u00e4l\u00e4inen JI. On the role of prolyl oligopeptidase in health and disease. Neuropeptides. 2007;41(1):1\u201324.","journal-title":"Neuropeptides"},{"issue":"9","key":"404_CR12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1369\/jhc.2009.953711","volume":"57","author":"TT My\u00f6h\u00e4nen","year":"2009","unstructured":"My\u00f6h\u00e4nen TT, Garc\u00eda-Horsman JA, Tenorio-Laranga J, M\u00e4nnist\u00f6 PT. Issues about the physiological functions of prolyl oligopeptidase based on its discordant spatial association with substrates and inconsistencies among mRNA, protein levels, and enzymatic activity. J Histochem Cytochem. 2009;57(9):831\u201348.","journal-title":"J Histochem Cytochem"},{"issue":"5","key":"404_CR13","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/cne.21642","volume":"507","author":"TT My\u00f6h\u00e4nen","year":"2008","unstructured":"My\u00f6h\u00e4nen TT, Ven\u00e4l\u00e4inen JI, Garc\u00eda-Horsman JA, Piltonen M, M\u00e4nnist\u00f6 PT. Cellular and subcellular distribution of rat brain prolyl oligopeptidase and its association with specific neuronal neurotransmitters. J Comp Neurol. 2008;507(5):1694\u2013708.","journal-title":"J Comp Neurol"},{"issue":"2","key":"404_CR14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neulet.2008.11.038","volume":"450","author":"TT My\u00f6h\u00e4nen","year":"2009","unstructured":"My\u00f6h\u00e4nen TT, K\u00e4\u00e4ri\u00e4inen TM, Jalkanen AJ, Piltonen M, M\u00e4nnist\u00f6 PT. Localization of prolyl oligopeptidase in the thalamic and cortical projection neurons: a retrograde neurotracing study in the rat brain. Neurosci Lett. 2009;450(2):201\u20135.","journal-title":"Neurosci Lett"},{"issue":"2","key":"404_CR15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000326342","volume":"19","author":"MJ Moreno-Baylach","year":"2011","unstructured":"Moreno-Baylach MJ, Puttonen KA, Tenorio-Laranga J, Ven\u00e4l\u00e4inen JI, Storvik M, Forsberg MM, et al. Prolyl endopeptidase is involved in cellular signalling in human neuroblastoma SH-SY5Y cells. Neurosignals. 2011;19(2):97\u2013109.","journal-title":"Neurosignals"},{"issue":"3","key":"404_CR16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.neuroscience.2008.06.072","volume":"156","author":"MJ Moreno-Baylach","year":"2008","unstructured":"Moreno-Baylach MJ, Felipo V, M\u00e4nnist\u00f6 PT, Garc\u00eda-Horsman JA. Expression and traffic of cellular prolyl oligopeptidase are regulated during cerebellar granule cell differentiation, maturation, and aging. Neuroscience. 2008;156(3):580\u20135.","journal-title":"Neuroscience"},{"issue":"1\u20133","key":"404_CR17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.regpep.2006.10.004","volume":"139","author":"N Agirregoitia","year":"2007","unstructured":"Agirregoitia N, Casis L, Gil J, Ruiz F, Irazusta J. Ontogeny of prolyl endopeptidase and pyroglutamyl peptidase I in rat tissues. Regul Pept. 2007;139(1\u20133):52\u20138.","journal-title":"Regul Pept"},{"issue":"1","key":"404_CR18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000322082","volume":"33","author":"MJ Hannula","year":"2011","unstructured":"Hannula MJ, M\u00e4nnist\u00f6 PT, My\u00f6h\u00e4nen TT. Sequential expression, activity and nuclear localization of prolyl oligopeptidase protein in the developing rat brain. Dev Neurosci. 2011;33(1):38\u201347.","journal-title":"Dev Neurosci"},{"key":"404_CR19","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.bcp.2013.04.018","volume":"85","author":"J Tenorio-Laranga","year":"2013","unstructured":"Tenorio-Laranga J, Peltonen I, Keskitalo S, Duran-Torres G, Natarajan R, Mannisto PT, et al. Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome. Biochem Pharmacol. 2013;85:1783\u201394.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"404_CR20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2174\/187152711794653742","volume":"10","author":"A Penttinen","year":"2011","unstructured":"Penttinen A, Tenorio-Laranga J, Siikanen A, Morawski M, Rossner S, Garc\u00eda-Horsman JA. Prolyl oligopeptidase: a rising star on the stage of neuroinflammation research. CNS Neurol Disord Drug Targets. 2011;10(3):340\u20138.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"404_CR21","first-page":"32","volume":"4","author":"A Gaggar","year":"2010","unstructured":"Gaggar A, Rowe SM, Matthew H, Blalock JE. Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): potential mediators of cystic fibrosis airway inflammation. Open Respir Med J. 2010;4:32\u20138.","journal-title":"Open Respir Med J"},{"key":"404_CR22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroscience.2013.03.049","volume":"242","author":"MJ Hannula","year":"2013","unstructured":"Hannula MJ, Myohanen TT, Tenorio-Laranga J, Mannisto PT, Garcia-Horsman JA. Prolyl oligopeptidase colocalizes with alpha-synuclein, beta-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases. Neuroscience. 2013;242:140\u201350.","journal-title":"Neuroscience"},{"issue":"3","key":"404_CR23","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1476-5381.2012.01846.x","volume":"166","author":"TT My\u00f6h\u00e4nen","year":"2012","unstructured":"My\u00f6h\u00e4nen TT, Hannula MJ, Van Elzen R, Gerard M, Van Der Veken P, Garc\u00eda-Horsman JA, et al. A prolyl oligopeptidase inhibitor, KYP-2047, reduces alpha-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease. Br J Pharmacol. 2012;166(3):1097\u2013113.","journal-title":"Br J Pharmacol"},{"key":"404_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neulet.2014.09.026","volume":"583C","author":"L Dokleja","year":"2014","unstructured":"Dokleja L, Hannula MJ, My\u00f6h\u00e4nen TT. Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers. Neurosci Lett. 2014;583C:37\u201342.","journal-title":"Neurosci Lett"},{"issue":"32","key":"404_CR25","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1073\/pnas.1406000111","volume":"111","author":"JD Kim","year":"2014","unstructured":"Kim JD, Toda C, D'Agostino G, Zeiss CJ, DiLeone RJ, Elsworth JD, et al. Hypothalamic prolyl endopeptidase (PREP) regulates pancreatic insulin and glucagon secretion in mice. Proc Natl Acad Sci U S A. 2014;111(32):11876\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"404_CR26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/187152711794653841","volume":"10","author":"J Tenorio-Laranga","year":"2011","unstructured":"Tenorio-Laranga J, M\u00e4nnist\u00f6 PT, Garc\u00eda-Horsman JA. Hunting for peptide substrates of prolyl oligopeptidase: classical versus non-classical bioactive peptides. CNS Neurol Disord Drug Targets. 2011;10(3):319\u201326.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"9","key":"404_CR27","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.biochi.2012.04.005","volume":"94","author":"J Tenorio-Laranga","year":"2012","unstructured":"Tenorio-Laranga J, M\u00e4nnist\u00f6 PT, Storvik M, Van der Veken P, Garc\u00eda-Horsman JA. Four day inhibition of prolyl oligopeptidase causes significant changes in the peptidome of rat brain, liver and kidney. Biochimie. 2012;94(9):1849\u201359.","journal-title":"Biochimie"},{"issue":"6","key":"404_CR28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/glia.20645","volume":"56","author":"A Klegeris","year":"2008","unstructured":"Klegeris A, Li J, Bammler TK, Jin J, Zhu D, Kashima DT, et al. Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP-1 cell neurotoxicity. Glia. 2008;56(6):675\u201385.","journal-title":"Glia"},{"key":"404_CR29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1465-9921-10-38","volume":"10","author":"P O'Reilly","year":"2009","unstructured":"O'Reilly P, Jackson PL, Noerager B, Parker S, Dransfield M, Gaggar A, et al. N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD. Respir Res. 2009;10:38.","journal-title":"Respir Res"},{"issue":"1","key":"404_CR30","doi-asserted-by":"crossref","first-page":"e55612","DOI":"10.1371\/journal.pone.0055612","volume":"8","author":"SA Overbeek","year":"2013","unstructured":"Overbeek SA, Braber S, Koelink PJ, Henricks PA, Mortaz E, LoTam Loi AT, et al. Cigarette smoke-induced collagen destruction; key to chronic neutrophilic airway inflammation? PLoS One. 2013;8(1):e55612.","journal-title":"PLoS One"},{"issue":"4\u20135","key":"404_CR31","first-page":"273","volume":"7","author":"T Aoyagi","year":"1985","unstructured":"Aoyagi T, Wada T, Kojima F, Nagai M, Okubo M, Masaki Y, et al. Abnormality of the post-proline-cleaving enzyme activity in mice with systemic lupus erythematosus-like syndrome. J Appl Biochem. 1985;7(4\u20135):273\u201381.","journal-title":"J Appl Biochem"},{"issue":"8","key":"404_CR32","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/clinchem\/33.8.1463","volume":"33","author":"M Hagihara","year":"1987","unstructured":"Hagihara M, Ohhashi M, Nagatsu T. Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in mice with lupus erythematosus-like syndrome and in patients with lupus erythematosus and rheumatoid arthritis. Clin Chem. 1987;33(8):1463\u20135.","journal-title":"Clin Chem"},{"issue":"6","key":"404_CR33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/clinchem\/35.6.1016","volume":"35","author":"H Gotoh","year":"1989","unstructured":"Gotoh H, Hagihara M, Nagatsu T, Iwata H, Miura T. Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Chem. 1989;35(6):1016\u20138.","journal-title":"Clin Chem"},{"issue":"2\u20133","key":"404_CR34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0009-8981(87)90139-2","volume":"170","author":"A Ito","year":"1987","unstructured":"Ito A, Hagihara M, Nagatsu T, Iwata H, Miura T. Collagenase-like (CL) peptidase activity in synovial fluid from patients with rheumatoid arthritis. Clin Chim Acta. 1987;170(2\u20133):291\u20136.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"404_CR35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0885-4505(91)90016-E","volume":"45","author":"M Kamori","year":"1991","unstructured":"Kamori M, Hagihara M, Nagatsu T, Iwata H, Miura T. Activities of dipeptidyl peptidase II, dipeptidyl peptidase IV, prolyl endopeptidase, and collagenase-like peptidase in synovial membrane from patients with rheumatoid arthritis and osteoarthritis. Biochem Med Metab Biol. 1991;45(2):154\u201360.","journal-title":"Biochem Med Metab Biol"},{"issue":"7","key":"404_CR36","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.4049\/jimmunol.0802457","volume":"182","author":"MT Hardison","year":"2009","unstructured":"Hardison MT, Galin FS, Calderon CE, Djekic UV, Parker SB, Wille KM, et al. The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation. J Immunol. 2009;182(7):4423\u201331.","journal-title":"J Immunol"},{"key":"404_CR37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-7-23","volume":"7","author":"J Tenorio-Laranga","year":"2010","unstructured":"Tenorio-Laranga J, Coret-Ferrer F, Casanova-Estruch B, Burgal M, Garc\u00eda-Horsman JA. Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis. J Neuroinflammation. 2010;7:23.","journal-title":"J Neuroinflammation"},{"key":"404_CR38","first-page":"668","volume":"50","author":"SH Lee","year":"1961","unstructured":"Lee SH, Fisher B. Portacaval shunt in the rat. Surgery. 1961;50:668\u201372.","journal-title":"Surgery"},{"issue":"6","key":"404_CR39","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/jnr.21947","volume":"87","author":"O Cauli","year":"2009","unstructured":"Cauli O, Rodrigo R, Piedrafita B, Llansola M, Mansouri MT, Felipo V. Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy. Ibuprofen restores its motor activity. J Neurosci Res. 2009;87(6):1369\u201374.","journal-title":"J Neurosci Res"},{"key":"404_CR40","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1478-3231.2005.01066.x","volume":"25","author":"C Montoliu","year":"2005","unstructured":"Montoliu C, Kosenko E, del Olmo JA, Serra MA, Rodrigo JM, Felipo V. Correlation of nitric oxide and atrial natriuretic peptide changes to altered cGMP homeostasis in liver cirrhosis. Liver Int. 2005;25:787\u201379.","journal-title":"Liver Int"},{"issue":"3","key":"404_CR41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00109-006-0149-y","volume":"85","author":"C Montoliu","year":"2007","unstructured":"Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Ferrandez A, Rodrigo JM, et al. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients. J Mol Med. 2007;85(3):237\u201345.","journal-title":"J Mol Med"},{"issue":"1","key":"404_CR42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11011-011-9269-3","volume":"27","author":"V Felipo","year":"2012","unstructured":"Felipo V, Urios A, Montesinos E, Molina I, Garcia-Torres ML, Civera M, et al. Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. Metab Brain Dis. 2012;27(1):51\u20138.","journal-title":"Metab Brain Dis"},{"issue":"1","key":"404_CR43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11011-010-9184-z","volume":"25","author":"C Montoliu","year":"2010","unstructured":"Montoliu C, Rodrigo R, Monfort P, Llansola M, Cauli O, Boix J, et al. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications. Metab Brain Dis. 2010;25(1):39\u201348.","journal-title":"Metab Brain Dis"},{"issue":"9","key":"404_CR44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrgastro.2013.99","volume":"10","author":"RF Butterworth","year":"2013","unstructured":"Butterworth RF. The liver-brain axis in liver failure: neuroinflammation and encephalopathy. Nat Rev Gastroenterol Hepatol. 2013;10(9):522\u20138.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"404_CR45","doi-asserted-by":"crossref","first-page":"L255","DOI":"10.1152\/ajplung.00304.2010","volume":"300","author":"S Braber","year":"2011","unstructured":"Braber S, Koelink PJ, Henricks PA, Jackson PL, Nijkamp FP, Garssen J, et al. Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown. Am J Physiol Lung Cell Mol Physiol. 2011;300(2):L255\u201365.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"404_CR46","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3390\/molecules17033586","volume":"17","author":"X Chu","year":"2012","unstructured":"Chu X, Ci X, He J, Jiang L, Wei M, Cao Q, et al. Effects of a natural prolyl oligopeptidase inhibitor, rosmarinic acid, on lipopolysaccharide-induced acute lung injury in mice. Molecules. 2012;17(3):3586\u201398.","journal-title":"Molecules"},{"issue":"8","key":"404_CR47","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.4049\/jimmunol.180.8.5662","volume":"180","author":"A Gaggar","year":"2008","unstructured":"Gaggar A, Jackson PL, Noerager BD, O'Reilly PJ, McQuaid DB, Rowe SM, et al. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol. 2008;180(8):5662\u20139.","journal-title":"J Immunol"},{"issue":"1","key":"404_CR48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2004.01.176","volume":"316","author":"H Kakegawa","year":"2004","unstructured":"Kakegawa H, Matano Y, Inubushi T, Katunuma N. Significant accumulations of cathepsin B and prolylendopeptidase in inflammatory focus of delayed-type hypersensitivity induced by Mycobacterium tuberculosis in mice. Biochem Biophys Res Commun. 2004;316(1):78\u201384.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"404_CR49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2009.09.020","volume":"217","author":"PJ O'Reilly","year":"2009","unstructured":"O'Reilly PJ, Hardison MT, Jackson PL, Xu X, Snelgrove RJ, Gaggar A, et al. Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen. J Neuroimmunol. 2009;217(1\u20132):51\u20134.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"404_CR50","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/01.HYP.0000126172.01673.84","volume":"43","author":"MA Cavasin","year":"2004","unstructured":"Cavasin MA, Rhaleb NE, Yang XP, Carretero OA. Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP. Hypertension. 2004;43(5):1140\u20135.","journal-title":"Hypertension"},{"issue":"8","key":"404_CR51","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1476-5381.2010.01146.x","volume":"163","author":"TT My\u00f6h\u00e4nen","year":"2011","unstructured":"My\u00f6h\u00e4nen TT, Tenorio-Laranga J, Jokinen B, Vazquez-Sanchez R, Moreno-Baylach M, Garc\u00eda-Horsman JA, et al. Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner. Br J Pharmacol. 2011;163(8):1666\u201378.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"404_CR52","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1161\/01.HYP.37.2.794","volume":"37","author":"H Peng","year":"2001","unstructured":"Peng H, Carretero OA, Raij L, Yang F, Kapke A, Rhaleb NE. Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats. Hypertension. 2001;37(2):794\u2013800.","journal-title":"Hypertension"},{"issue":"10","key":"404_CR53","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/ars.2014.6240","volume":"22","author":"C Gimenez-Garz\u00f3","year":"2015","unstructured":"Gimenez-Garz\u00f3 C, Urios A, Agust\u00ed A, Gonz\u00e1lez-L\u00f3pez O, Escudero-Garc\u00eda D, Escudero-Sanchis A, et al. Is cognitive impairment in cirrhotic patients due to increased peroxynitrite and oxidative stress? Antioxid Redox Signal. 2015;22(10):871\u20137.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"404_CR54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","volume":"124","author":"R Wiesner","year":"2003","unstructured":"Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterol. 2003;124(1):91\u20136.","journal-title":"Gastroenterol"},{"key":"404_CR55","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1046\/j.1460-9568.1998.00329.x","volume":"10","author":"C Hermenegildo","year":"1998","unstructured":"Hermenegildo C, Montoliu C, Llansola M, Mu\u00f1oz MD, Gaztelu JM, Mi\u00f1ana MD, et al. Chronic hyperammonemia impairs glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur J Neurosci. 1998;10:3201\u20139.","journal-title":"Eur J Neurosci."},{"issue":"14","key":"404_CR56","doi-asserted-by":"crossref","first-page":"9675","DOI":"10.1074\/jbc.M113.455162","volume":"288","author":"M Belghiti","year":"2013","unstructured":"Belghiti M, Estevez-Herrera J, Gimenez-Garzo C, Gonzalez-Usano A, Montoliu C, Ferrer-Montiel A, et al. Potentiation of the transient receptor potential vanilloid 1 channel contributes to pruritogenesis in a rat model of liver disease. J Biol Chem. 2013;288(14):9675\u201385.","journal-title":"J Biol Chem"},{"issue":"2","key":"404_CR57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1478-3231.2004.0894.x","volume":"24","author":"M Odeh","year":"2004","unstructured":"Odeh M, Sabo E, Srugo I, Oliven A. Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure. Liver Int. 2004;24(2):110\u20136.","journal-title":"Liver Int"},{"issue":"8","key":"404_CR58","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/07853890500317414","volume":"37","author":"M Odeh","year":"2005","unstructured":"Odeh M, Sabo E, Srugo I, Oliven A. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure. Ann Intern Med. 2005;37(8):603\u201312.","journal-title":"Ann Intern Med"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-015-0404-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:36:31Z","timestamp":1599611791000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jneuroinflammation.com\/content\/12\/1\/183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,30]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["404"],"URL":"https:\/\/doi.org\/10.1186\/s12974-015-0404-7","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,30]]},"article-number":"183"}}